Anti-BNIP1 antibody produced in rabbit，100UL，HPA008009-100UL，Sigma

Immunogen

Vesicle transport protein SEC20 recombinant protein epitope signature tag (PrEST)

Application

All Prestige Antibodies Powered by Atlas Antibodies are developed and validated by the Human Protein Atlas (HPA) project and as a result, are supported by the most extensive characterization in the industry.

The Human Protein Atlas project can be subdivided into three efforts: Human Tissue Atlas, Cancer Atlas, and Human Cell Atlas. The antibodies that have been generated in support of the Tissue and Cancer Atlas projects have been tested by immunohistochemistry against hundreds of normal and disease tissues and through the recent efforts of the Human Cell Atlas project, many have been characterized by immunofluorescence to map the human proteome not only at the tissue level but now at the subcellular level. These images and the collection of this vast data set can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. We also provide Prestige Antibodies^® protocols and other useful information.

Biochem/physiol Actions

BNIP1 (BCL2/adenovirus E1B 19kDa interacting protein 1) gene encodes a member of the BNIP family. The encoded protein is capable of interacting with the antiapoptotic adenovirus E1B 19-kDa protein. It is a component of a complex containing the SNARE protein, syntaxin 18. BNIP1 functions in the formation of the ER network structure and ER membrane fusion. The BH3 domain of BNIP1 contains a highly conserved leucine residue that has been implicated in apoptosis. It is also involved in the regulation of mitochondrial autophagy, a process that facilitates the recycling of cytoplasmic organelles for cell survival.

Features and Benefits

Prestige Antibodies^® are highly characterized and extensively validated antibodies with the added benefit of all available characterization data for each target being accessible via the Human Protein Atlas portal linked just below the product name at the top of this page. The uniqueness and low cross-reactivity of the Prestige Antibodies^® to other proteins are due to a thorough selection of antigen regions, affinity purification, and stringent selection. Prestige antigen controls are available for every corresponding Prestige Antibody and can be found in the linkage section.

Every Prestige Antibody is tested in the following ways:

• IHC tissue array of 44 normal human tissues and 20 of the most common cancer type tissues.
• Protein array of 364 human recombinant protein fragments.

Physical form

Solution in phosphate-buffered saline, pH 7.2, containing 40% glycerol and 0.02% sodium azide

Other Notes

Corresponding Antigen APREST71816

Legal Information

Prestige Antibodies is a registered trademark of Merck KGaA, Darmstadt, Germany